167 related articles for article (PubMed ID: 36569871)
21. The Prognostic Model Established by the Differential Expression Genes Based on CD8
Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H
Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
[TBL] [Abstract][Full Text] [Related]
24. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
25. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
[TBL] [Abstract][Full Text] [Related]
26. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
27. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
Chen S; Zeng J; Huang L; Peng Y; Yan Z; Zhang A; Zhao X; Li J; Zhou Z; Wang S; Jing S; Hu M; Li Y; Wang D; Wang W; Yu H; Miao J; Li J; Deng Y; Li Y; Liu T; Xu D
J Transl Med; 2022 May; 20(1):228. PubMed ID: 35568866
[TBL] [Abstract][Full Text] [Related]
28. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
29. Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Yang B; Su Z; Chen G; Zeng Z; Tan J; Wu G; Zhu S; Lin L
Oncol Lett; 2021 Mar; 21(3):180. PubMed ID: 33574919
[TBL] [Abstract][Full Text] [Related]
30. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
31. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
Huang W; Xiao Y; Wang H; Chen G; Li K
Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
[TBL] [Abstract][Full Text] [Related]
32. A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients.
Wu B; Wang Z; Lin N; Yan X; Lv Z; Ying Z; Ye Z
Medicine (Baltimore); 2021 Apr; 100(14):e24118. PubMed ID: 33832059
[TBL] [Abstract][Full Text] [Related]
33. [Bioinformatics Analysis on Key Genes and Immune Infiltration of Osteosarcoma].
Li S; Zheng ZZ; Zhang YP; Liu ZQ; Xiao SP; Ouyang ZX; Wang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):110-117. PubMed ID: 35300772
[TBL] [Abstract][Full Text] [Related]
34. A novel risk score model based on glycolysis-related genes and a prognostic model for predicting overall survival of osteosarcoma patients.
Chen W; Lin Y; Huang J; Yan Z; Cao H
J Orthop Res; 2022 Oct; 40(10):2372-2381. PubMed ID: 34997639
[TBL] [Abstract][Full Text] [Related]
35. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma.
Xu A; Qian C; Lin J; Yu W; Jin J; Liu B; Tao H
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828292
[TBL] [Abstract][Full Text] [Related]
36. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
[TBL] [Abstract][Full Text] [Related]
37. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of cancer-intrinsic immune evasion genes indicates prognosis and tumour microenvironment infiltration in osteosarcoma.
Zhao X; Zhang J; Liu J; Luo S; Ding R; Miao X; Wu T; Jia J; Cheng X
Aging (Albany NY); 2023 Oct; 15(19):10272-10290. PubMed ID: 37796192
[TBL] [Abstract][Full Text] [Related]
39. Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration.
Qiu X; He H; Zeng H; Tong X; Zhang C; Liu Y; Liao Z; Liu Q
Genes Dis; 2024 May; 11(3):101004. PubMed ID: 38292182
[TBL] [Abstract][Full Text] [Related]
40. Infiltration of LPAR5
He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
Front Immunol; 2022; 13():909932. PubMed ID: 36591220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
